Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: REPROCELL U.S.A., INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-01-05 to 2023-07-05
Current total value of award: $17016.8
Description: QUOTE MS11172022 THIS PROJECT IS NECESSARY FOR CDS BECAUSE WITHOUT IT THE A WHOLE PART OF THE INTEGRATIVE APPROACH USED BY CDS WILL NOT BE POSSIBLE; IT WILL NOT BE POSSIBLE TO INVESTIGATE GENETIC AND EPIGENETIC EFFECT AT TRANSCRIPTOME LEVEL